Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine

Summary

This is a prospective, randomized, vehicle-controlled, double-blind, multi-center study assessing the safety, tolerability, and efficacy of B244 delivered as an intranasal spray for preventive treatment in subjects with episodic migraine.

Timeline

Start

2018-03-30

Primary completion

2019-06-17

Completion

2019-07-16

Drugs

Indications